Literature DB >> 10886403

Activation of human Vgamma9Vdelta2 T cells by a Brucella suis non-peptidic fraction impairs bacterial intracellular multiplication in monocytic infected cells.

F Ottones1, J Liautard, A Gross, F Rabenoelina, J P Liautard, J Favero.   

Abstract

Human gamma delta T cells are considered to play an important role in the early response to infection with intracellular pathogens. Evidence has been presented that the percentage of gamma delta T cells with Vgamma9Vdelta2 phenotype is dramatically increased in the peripheral blood of patients with acute brucellosis. This specific gd T-cell subpopulation is known to be activated by small non-peptidic molecules that can either be produced by the pathogen itself or released from damaged cells after infection. In the present work we provide evidence that Vgamma9Vdelta2 T lymphocytes from peripheral blood mononuclear cells of healthy donors can be specifically activated by non-peptidic low-molecular-weight compound(s) from Brucella suis lysate. Moreover, we show that Vgamma9Vdelta2 T cells activated by this B. suis fraction produce tumour necrosis factor-alpha and interferon-gamma, which reduce bacterial multiplication inside infected cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886403      PMCID: PMC2326996          DOI: 10.1046/j.1365-2567.2000.00024.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Increased gamma delta T cells in acute Plasmodium falciparum malaria.

Authors:  M Ho; H K Webster; P Tongtawe; K Pattanapanyasat; W P Weidanz
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

2.  Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.

Authors:  Y Poquet; M Kroca; F Halary; S Stenmark; M A Peyrat; M Bonneville; J J Fournié; A Sjöstedt
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  Human immune response to Brucella infection.

Authors:  A Serre; S Bascoul; J P Vendrell; A Cannat
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Jan-Feb

5.  Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.

Authors:  L N Araya; P H Elzer; G E Rowe; F M Enright; A J Winter
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

6.  Differential nitric oxide and TNF-alpha production of murine Kupffer cell subfractions upon priming with IFN-gamma and TNF-alpha.

Authors:  T L ten Hagen; W van Vianen; H Heremans; I A Bakker-Woudenberg
Journal:  Liver       Date:  1998-10

7.  Gamma delta T lymphocytes in human tuberculosis.

Authors:  P F Barnes; C L Grisso; J S Abrams; H Band; T H Rea; R L Modlin
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

8.  Gamma delta T cells and the immune response in visceral leishmaniasis.

Authors:  S Raziuddin; A W Telmasani; M el-Hag el-Awad; O al-Amari; M al-Janadi
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

9.  Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection.

Authors:  P De Paoli; D Gennari; P Martelli; V Cavarzerani; R Comoretto; G Santini
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

10.  A subset of gamma delta lymphocytes is increased during HIV-1 infection.

Authors:  P De Paoli; D Gennari; P Martelli; G Basaglia; M Crovatto; S Battistin; G Santini
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

View more
  8 in total

1.  Responses of bovine WC1(+) gammadelta T cells to protein and nonprotein antigens of Mycobacterium bovis.

Authors:  Michael D Welsh; Hilary E Kennedy; Allister J Smyth; R Martyn Girvin; Peter Andersen; John M Pollock
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Gamma/delta T cells in patients with acute brucellosis.

Authors:  S S Kilic; H H Akbulut; M Ozden; V Bulut
Journal:  Clin Exp Med       Date:  2008-12-02       Impact factor: 3.984

3.  Identification and isolation of Brucella suis virulence genes involved in resistance to the human innate immune system.

Authors:  Janny Liautard; Safia Ouahrani-Bettache; Véronique Jubier-Maurin; Virginie Lafont; Stephan Köhler; Jean-Pierre Liautard
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

Review 4.  Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Authors:  Jinkyung Ko; Gary A Splitter
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

5.  Impairment of intramacrophagic Brucella suis multiplication by human natural killer cells through a contact-dependent mechanism.

Authors:  Jacques Dornand; Virginie Lafont; Jane Oliaro; Annie Terraza; Elsa Castaneda-Roldan; Jean-Pierre Liautard
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

6.  Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.

Authors:  Jianwu Pei; Xicheng Ding; Yaping Fan; Allison Rice-Ficht; Thomas A Ficht
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

Review 7.  Antigen-specific T cells and cytokines detection as useful tool for understanding immunity against zoonotic infections.

Authors:  Annalisa Agnone; Alessandra Torina; Gesualdo Vesco; Sara Villari; Fabrizio Vitale; Santo Caracappa; Marco Pio La Manna; Francesco Dieli; Guido Sireci
Journal:  Clin Dev Immunol       Date:  2012-02-09

8.  In vivo manipulation of γ9(+) T cells in the common marmoset (Callithrix Jacchus) with phosphoantigen and effect on the progression of respiratory melioidosis.

Authors:  Thomas R Laws; Michelle Nelson; Cecile Bonnafous; Helene Sicard; Christopher Taylor; Francisco Javier Salguero; Timothy P Atkins; Petra C F Oyston; Caroline A Rowland
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.